Banner BSP 5th Annual Highly Potent Active Pharmaceutical Ingredients Summit

(2 – 4 October 2019 – Rome, Italy)

BSP Pharmaceuticals S.p.A. is glad to announce its participation to the next 5th Edition of the Highly Potent Active Pharmaceutical Ingedients Summit from 2 to 4 October 2019 in Rome, Italy.

The Highly Potent Active Pharmaceutical Ingredients Summit is organized by VonlantheN Group.

This event provides its participants access to other industry leaders and an environment to discuss process innovation and technology and safety perspectives for both highly potent active pharmaceutical ingredient (HPAPI) manufacturers and outsourcers. This Summit will focus on current market trends for HPAPIs, including process development and scale-up, cost-effective production, containment innovations and best manufacturing practices as well as regulatory updates.

The key topics of the Summit are:

EMA requirements and considerations
Latest containment technologies and handling
Assuring regulatory compliance with the permitted daily exposure
Avoiding major HPAPI project issues
Hazard assessment classifications
Reducing risk – by design
Prevention of cross-contamination
Defining exposure controls in the workplace
Advanced therapies: are they HPAPI?

Save the Date!!! During the Conference Day 2 (Thursday 2nd of October), at the 12.35 AM for the Sponsored Speaking Slot, Fabio Zenobi (EHS & Toxicology Director) and Marina Martinelli (EHS Coordinator) will presents the speech ‘Manufacturing of Oncological Products by a CDMO.

To request a meeting, You can send an e-mail at info@bsppharmaceuticals.com